Skip to content

SCHEDULE 13DAccepted Apr 2, 6:32 PM ET

Vivos Therapeutics, Inc. SCHEDULE 13D

V-Co Investors 3 LLC

sec.gov(opens the filing on sec.gov)

Accepted (ET)

6:32 PM

Apr 2, 2026

Filed

Apr 2, 2026

Documents

2

Size

30.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.